Reynolds KL - Search Results

1

Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.

Reynolds KL, Guidon AC. Reynolds KL, et al. Oncologist. 2019 Apr;24(4):435-443. doi: 10.1634/theoncologist.2018-0359. Epub 2018 Nov 27. Oncologist. 2019. PMID: 30482825 Free PMC article. Review.

2

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade.

Reynolds K, Thomas M, Dougan M. Reynolds K, et al. Oncologist. 2018 Sep;23(9):991-997. doi: 10.1634/theoncologist.2018-0174. Epub 2018 May 31. Oncologist. 2018. PMID: 29853659 Free PMC article.

3

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies.

Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Dubey D, et al. Among authors: reynolds kl. Neurology. 2019 Sep 10;93(11):e1093-e1103. doi: 10.1212/WNL.0000000000008091. Epub 2019 Aug 12. Neurology. 2019. PMID: 31405908

4

Diagnosis and Management of Rare Immune-Related Adverse Events.

Schoenfeld SR, Aronow ME, Leaf RK, Dougan M, Reynolds KL. Schoenfeld SR, et al. Among authors: reynolds kl. Oncologist. 2020 Jan;25(1):6-14. doi: 10.1634/theoncologist.2019-0083. Epub 2019 Nov 6. Oncologist. 2020. PMID: 31694890 Free PMC article.

5

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.

Dubey D, David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Dubey D, et al. Among authors: reynolds kl. Ann Neurol. 2020 May;87(5):659-669. doi: 10.1002/ana.25708. Epub 2020 Mar 10. Ann Neurol. 2020. PMID: 32086972

6

Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors.

Petrillo LA, El-Jawahri A, Nipp RD, Lichtenstein MRL, Durbin SM, Reynolds KL, Greer JA, Temel JS, Gainor JF. Petrillo LA, et al. Among authors: reynolds kl. Cancer. 2020 May 15;126(10):2288-2295. doi: 10.1002/cncr.32782. Epub 2020 Mar 6. Cancer. 2020. PMID: 32142165 Free article.

7

Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.

Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL. Zubiri L, et al. Among authors: reynolds kl. Oncologist. 2020 Mar;25(3):e398-e404. doi: 10.1634/theoncologist.2018-0883. Epub 2019 Nov 21. Oncologist. 2020. PMID: 32162817 Free PMC article.

8

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.

Darnell EP, Mooradian MJ, Baruch EN, Yilmaz M, Reynolds KL. Darnell EP, et al. Among authors: reynolds kl. Curr Oncol Rep. 2020 Mar 21;22(4):39. doi: 10.1007/s11912-020-0897-9. Curr Oncol Rep. 2020. PMID: 32200442 Review.

9

Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.

Johnson DB, Reynolds KL, Sullivan RJ, Balko JM, Patrinely JR, Cappelli LC, Naidoo J, Moslehi JJ. Johnson DB, et al. Among authors: reynolds kl. Lancet Oncol. 2020 Aug;21(8):e398-e404. doi: 10.1016/S1470-2045(20)30107-8. Lancet Oncol. 2020. PMID: 32758477 Review.

10

Liver biopsy findings in patients on immune checkpoint inhibitors.

Cohen JV, Dougan M, Zubiri L, Reynolds KL, Sullivan RJ, Misdraji J. Cohen JV, et al. Among authors: reynolds kl. Mod Pathol. 2021 Feb;34(2):426-437. doi: 10.1038/s41379-020-00653-1. Epub 2020 Sep 3. Mod Pathol. 2021. PMID: 32884128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page